A Prospective Open Label, Single Center, Single-Arm Trial to evaluate the efficacy of AP-BioÂ®/KalmColdÂ® Capsules in enhancing the immunity and to evaluate its safety in healthy adults

Health Care Company Natural Products0 个研究点目标入组 30 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male or female subjects aged between 18-60 years with BMI 18 to 30 kg/m2.
•2.Healthy subjects as determined by: Medical history, Physical examination and Clinical judgment of the Investigator.
•3.Devoid of any medication during last one month.
•4.Subject provides written informed consent and comes for regular follow up.

•1.Female subjects who are pregnant, lactating or planning to become pregnant during the study period.
•2.Subjects receiving influenza vaccination within 3 months before the screening examination.
•3.Subjects with a clinically significant acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, liver biliary system, kidney and urinary system, neuropsychiatry, musculoskeletal system, inflammatory and hematologic.
•4.Subjects suffering from different diseases/disorders and/or having any kind of allergy, undergone surgery during last one year.
•5.Subjects who have received organ transplant, chronic smokers, underlying conditions which might affect immunity.
•6.Subjects who take a medication or health function food that affects your promotion of immunity within 1 month prior to the screening examination.
•7.Subjects receiving antipsychotic medication within 3 months prior to the screening examination.
•8.Subjects who is alcoholic or drug abuse suspected.
•9.Subjects who have participated in other clinical trials within 3 months prior to the screening examination.

发起方

Health Care Company Natural Products